Pulmonary hypertension associated with left-sided heart disease.
Pulmonary hypertension (PH) denotes a poor prognosis in patients with left-sided heart disease. No study has demonstrated long-term benefit from PH drugs such as prostanoids, endothelin antagonists, and phosphodiesterase-5 inhibitors. In some cases, cautious use of PH drugs may be indicated. However, theoretic and practical concerns limit any formal recommendations.
Oudiz
Ronald J
RJ
David Geffen School of Medicine at UCLA, CA 90502-2006, USA. oudiz@humc.edu
D000959:Antihypertensive Agents / Q000627:therapeutic use; D015897:Comorbidity; D005080:Exercise Test; D006331:Heart Diseases / Q000453:epidemiology* / Q000601:surgery; D016027:Heart Transplantation; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology* / Q000503:physiopathology; D011379:Prognosis; D016277:Ventricular Function, Left
D000959:Antihypertensive Agents